Viemed Healthcare, Inc.VMDNASDAQ
Loading
Operating Income Growth AcceleratingAccelerating
Percentile Rank62
3Y CAGR-34.8%
5Y CAGR+5.1%
Year-over-Year Change
Year-over-year operating income growth rate
3Y CAGR
-34.8%/yr
vs +159.6%/yr prior
5Y CAGR
+5.1%/yr
Recent deceleration
Acceleration
-194.4pp
Decelerating
Percentile
P62
Within normal range
vs 5Y Ago
1.3x
Solid growth
Streak
3 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 38.94% |
| Q3 2025 | 25.04% |
| Q2 2025 | 17.47% |
| Q1 2025 | -40.47% |
| Q4 2024 | 14.64% |
| Q3 2024 | 55.64% |
| Q2 2024 | 64.07% |
| Q1 2024 | -58.33% |
| Q4 2023 | 25.75% |
| Q3 2023 | 44.98% |
| Q2 2023 | 50.00% |
| Q1 2023 | -45.27% |
| Q4 2022 | 140.57% |
| Q3 2022 | 46.75% |
| Q2 2022 | -55.47% |
| Q1 2022 | -51.81% |
| Q4 2021 | 59.82% |
| Q3 2021 | 9.57% |
| Q2 2021 | 100.00% |
| Q1 2021 | -74.71% |
| Q4 2020 | 30.37% |
| Q3 2020 | -68.58% |
| Q2 2020 | 178.63% |
| Q1 2020 | 147.98% |
| Q4 2019 | -17.91% |
| Q3 2019 | 6.33% |
| Q2 2019 | -54.56% |
| Q1 2019 | -1.70% |
| Q4 2018 | 6.64% |
| Q3 2018 | 18.79% |
| Q2 2018 | -6.45% |
| Q1 2018 | 127.83% |
| Q4 2017 | -66.34% |
| Q3 2017 | 66.76% |
| Q2 2017 | -17.00% |
| Q1 2017 | 110.60% |
| Q4 2016 | 256.83% |
| Q3 2016 | 0.00% |